Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

1.

Iron-based phosphate binders: do they offer advantages over currently available phosphate binders?

Negri AL, Ureña Torres PA.

Clin Kidney J. 2015 Apr;8(2):161-7. doi: 10.1093/ckj/sfu139. Epub 2014 Dec 30.

2.

Régulation de la phosphatémie: insuffisance rénale chronique et nouveaux facteurs l'influençant tels que le FGF23 (Fibroblast Growth Factor 23) et klotho.

Urena Torres P.

Nephrol Ther. 2015 Apr;11(2):125-8. doi: 10.1016/j.nephro.2015.03.002. French. No abstract available.

PMID:
25814426
3.

Opponent's comments.

Bover J, Evenepoel P, Ureña-Torres P, Vervloet MG, Brandenburg V, Mazzaferro S, Covic A, Goldsmith D, Massy ZA, Cozzolino M; CKD-MBD Working Group of ERA-EDTA.

Nephrol Dial Transplant. 2015 Mar;30(3):357. doi: 10.1093/ndt/gfv021a. No abstract available.

PMID:
25712937
4.

Pro: Cardiovascular calcifications are clinically relevant.

Bover J, Evenepoel P, Ureña-Torres P, Vervloet MG, Brandenburg V, Mazzaferro S, Covic A, Goldsmith D, Massy ZA, Cozzolino M; CKD-MBD Working Group of ERA-EDTA.

Nephrol Dial Transplant. 2015 Mar;30(3):345-51. doi: 10.1093/ndt/gfv020.

PMID:
25712934
5.

[Native vitamin D in dialysis patients].

Delanaye P, Bouquegneau A, Krzesinski JM, Cavalier É, Jean G, Urena-Torres P, Souberbielle JC.

Nephrol Ther. 2015 Feb;11(1):5-15. doi: 10.1016/j.nephro.2014.10.004. Epub 2015 Jan 14. French.

PMID:
25597001
6.

New insights into the FGF23-Klotho axis.

Olauson H, Vervloet MG, Cozzolino M, Massy ZA, Ureña Torres P, Larsson TE.

Semin Nephrol. 2014 Nov;34(6):586-97. doi: 10.1016/j.semnephrol.2014.09.005.

PMID:
25498378
7.

[Incidence and characteristics of calciphylaxis in Martinique (2006-2012)].

Aoun A, Baubion E, Banydeen R, Djiconkpode I, Ekindi N, Ureña-Torres P, Riaux A, Sadreux T, Dueymes JM, Quist D, Derancourt C.

Ann Dermatol Venereol. 2014 Dec;141(12):743-9. doi: 10.1016/j.annder.2014.06.008. Epub 2014 Aug 10. French.

PMID:
25433925
8.

[Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement].

Souberbielle JC, Benhamou CL, Cortet B, Rousière M, Roux C, Abitbol V, Annweiler C, Audran M, Bacchetta J, Bataille P, Beauchet O, Bardet R, Benachi A, Berenbaum F, Blain H, Borson-Chazot F, Breuil V, Briot K, Brunet P, Carel JC, Caron P, Chabre O, Chanson P, Chapurlat R, Cochat P, Coutant R, Christin-Maitre S, Cohen-Solal M, Combe C, Cormier C, Courbebaisse M, Debrus G, Delemer B, Deschenes G, Duquenne M, Fardellone P, Fouque D, Friedlander G, Gauvain JB, Groussin L, Guggenbuhl P, Houillier P, Hannedouche T, Jacot W, Javier RM, Jean G, Jeandel C, Joly D, Kamenicky P, Knebelmann B, Lafage-Proust MH, LeBouc Y, Legrand E, Levy-Weil F, Linglart A, Machet L, Maheu E, Mallet E, Marcelli C, Marès P, Mariat C, Maruani G, Maugars Y, Montagnon F, Moulin B, Orcel P, Partouche H, Personne V, Pierrot-Deseilligny C, Polak M, Pouteil-Noble C, Prié D, Raynaud-Simon A, Rolland Y, Sadoul JL, Salle B, Sault C, Schott AM, Sermet-Gaudelus I, Soubrier M, Tack I, Thervet É, Tostivint I, Touraine P, Tremollières F, Urena-Torres P, Viard JP, Wemeau JL, Weryha G, Winer N, Young J, Thomas T.

Ann Biol Clin (Paris). 2014 Jul-Aug;72(4):385-9. doi: 10.1684/abc.2014.0972. French. No abstract available.

PMID:
25119796
10.

Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders.

Vervloet MG, Massy ZA, Brandenburg VM, Mazzaferro S, Cozzolino M, Ureña-Torres P, Bover J, Goldsmith D; CKD-MBD Working Group of ERA-EDTA.

Lancet Diabetes Endocrinol. 2014 May;2(5):427-36. doi: 10.1016/S2213-8587(14)70059-2. Review.

PMID:
24795256
11.

Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?

Cozzolino M, Ureña-Torres P, Vervloet MG, Brandenburg V, Bover J, Goldsmith D, Larsson TE, Massy ZA, Mazzaferro S; CKD-MBD Working Group of ERA-EDTA.

Nephrol Dial Transplant. 2014 Oct;29(10):1815-20. doi: 10.1093/ndt/gft514. Epub 2014 Feb 9.

PMID:
24516228
12.

[HAS report on vitamin D measurement: don't go from an extreme situation to another as extreme situation].

Souberbielle JC, Benhamou CL, Cortet B, Rousière M, Roux C, Abitbol V, Audran M, Bachetta J, Beauchet O, Blain H, Breuil V, Briot K, Brunet P, Chanson P, Cormier C, Courbebaisse M, Fardellone P, Fouque D, Friedlander G, Gauvain JB, Groussin L, Houillier P, Jacot W, Jean G, Kamenicky P, Lafage-Proust MH, Legrand E, Levy-Weil F, Linglart A, Mallet E, Marcelli C, Maruani G, Montagnon F, Personne V, Prié D, Raynaud-Simon A, Rolland Y, Salle B, Sault C, Schott AM, Thervet E, Urena-Torres P, Viard JP, Weryha G, Pierrot-Deseilligny C, Young J, Thomas T.

Presse Med. 2014 Jan;43(1):5-8. doi: 10.1016/j.lpm.2013.12.005. French. No abstract available.

PMID:
24439118
13.

Sodium thiosulphate treatment of uraemic tumoral calcinosis.

Malbos S, Urena-Torres P, Cohen-Solal M, Trout H, Lioté F, Bardin T, Ea HK.

Rheumatology (Oxford). 2014 Mar;53(3):547-51. doi: 10.1093/rheumatology/ket388. Epub 2013 Nov 29.

PMID:
24292346
14.

Parathyroid scintigraphy in renal hyperparathyroidism: the added diagnostic value of SPECT and SPECT/CT.

Taïeb D, Ureña-Torres P, Zanotti-Fregonara P, Rubello D, Ferretti A, Henter I, Henry JF, Schiavi F, Opocher G, Blickman JG, Colletti PM, Hindié E.

Clin Nucl Med. 2013 Aug;38(8):630-5. doi: 10.1097/RLU.0b013e31829af5bf. Review.

15.

Pharmacologic role of vitamin D natural products.

Urena-Torres P, Souberbielle JC.

Curr Vasc Pharmacol. 2014 Mar;12(2):278-85. Review.

PMID:
23713872
16.

Cinacalcet for cardiovascular disease in patients undergoing dialysis.

Urena-Torres P, Prié D, Souberbielle JC.

N Engl J Med. 2013 May 9;368(19):1842-3. doi: 10.1056/NEJMc1301247#SA1. No abstract available. Erratum in: N Engl J Med. 2013 Sep 5;369(10):986.

PMID:
23656654
17.

Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold.

Metzger M, Houillier P, Gauci C, Haymann JP, Flamant M, Thervet E, Boffa JJ, Vrtovsnik F, Froissart M, Stengel B, Ureña-Torres P; NephroTest Study Group.

J Clin Endocrinol Metab. 2013 Jul;98(7):2922-8. doi: 10.1210/jc.2013-1294. Epub 2013 Apr 30.

PMID:
23633202
18.

[How parathyroid hormone (PTH) Does regulates calcium? Particulars of the patient with chronic kidney disease].

Ureña Torres P.

Nephrol Ther. 2013 Apr;9(2):125-8. doi: 10.1016/j.nephro.2013.02.005. French. No abstract available.

PMID:
23541302
19.

Calcium-mediated parathyroid hormone suppression to assess progression of secondary hyperparathyroidism during treatment among incident dialysis patients.

Rodriguez M, Ureña-Torres P, Pétavy F, Cooper K, Farouk M, Goodman WG.

J Clin Endocrinol Metab. 2013 Feb;98(2):618-25. doi: 10.1210/jc.2012-3246. Epub 2013 Jan 30.

PMID:
23365129
20.

Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism.

Ureña-Torres P, Bridges I, Christiano C, Cournoyer SH, Cooper K, Farouk M, Kopyt NP, Rodriguez M, Zehnder D, Covic A.

Nephrol Dial Transplant. 2013 May;28(5):1241-54. doi: 10.1093/ndt/gfs568. Epub 2013 Jan 16.

PMID:
23328710
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk